Last Updated : January 7, 2025
Details
FilesGeneric Name:
fidaxomicin
Project Status:
Active
Therapeutic Area:
Clostridium difficile infection
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0754-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
N/A
Indications:
For the treatment of adults with Clostridium difficile infection.
| Call for patient/clinician/industry input open | 21-Nov-24 |
|---|---|
| Call for patient/clinician/industry input closed | 17-Jan-25 |
| Submission received | November 22, 2024 |
| Expert committee meeting (initial) | May 15, 2025 |
Files
Last Updated : January 7, 2025